You are here


Found 110 results
Sort by: Author Title [ Type (Asc)] Year
Filters: Author is G. Bontempi  [Clear All Filters]
Journal Article
Bontempi G, Vaccaro A, Villacci D. A semi-physical modelling architecture for dynamic assessment of power components loading capability. IEE Proceedings of Generation Transmission and Distribution. 2004:533-542.
Moore F, Naamane N, Colli ML, Bouckenooghe T, Ortis F, Gurzov EN, Igoillo-Esteve M, Mathieu C, Bontempi G, Thykjaer T, et al. STAT1 is a master regulator of pancreatic beta cells apoptosis and islet inflammation. J. Biol. Chem. 2010.
Bontempi G. A statistic criterion for reducing indeterminacy in linear causal modeling. ICPRAM 2103 Conference. 2013.
Lefranc F, Spiegl-Kreinecker S, Haibe-Kains B, Bontempi G, Decaestecker C, Berger W, Kiss R. Temozolomide displays antimigratory effects in human glioblastoma cells mediated through neuregulin-1 down-regulation. Surgical Neurology. 2009:134 - 134.
Haibe-Kains B, Desmedt C, Loi S, Culhane AC, Bontempi G, Quackenbush J, Sotiriou C. A three-gene model to robustly identify breast cancer molecular subtypes. Journal of the National Cancer Institute. 2012:311–325.
Mijatovic T, Mahieu T, De Neve N, Dewelle J, Simon G, Dehoux MJM, van der Aar E, Haibe-Kains B, Bontempi G, Deacestecker C, et al. UNBS5162, a Novel Naphthalimide That Decreases CXCL Chemokine Expression in Experimental Prostate Cancers. Neoplasia. 2008:573-586.
Bontempi G, Kruijtzer W. The use of intelligent data analysis techniques for system-level design: a software estimation example. Soft Computing Journal. 2004:477-490.
Le Mercier M, Lefranc F, nd Debeir MTO, Haibe-Kains B, Bontempi G, Decaestecker C, Kiss R, Mathieu V. vidence of galectin-1 involvement in glioma chemoresistance. Toxicology and Applied Pharmacology. 2008:172-183.


Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer